Aviva Strategies has dedicated $100M to the RAPID program for rare disease patients.

Aviva Strategies is a boutique consulting firm headquartered in Washington, DC. We support health and life science clientele across multiple sectors, all of whom are on a mission to shake-up the status quo while ensuring that patients live longer, healthier lives. Service Offerings: Public Affairs, Government Affairs, & Public Policy STRATEGIC PLANNING: Crafting holistic strategies to guide the development or refresh of federal and state government affairs programs and initiatives LOBBYING & ADVOCACY: Connecting clients with key government decision makers in Congress, states, or in agencies (FDA, NIH, ARPA-H) POLICY ANALYSIS: Examining the impact of existing statute or proposed legislation on patients and the corporate sector COALITION BUILDING: Working with diverse stakeholders to build alignment and drive progress on public policy issues Patient Advocacy & Policymaker Education STRATEGY DEVELOPMENT: Partnering with patient advocacy leaders to bring focus and deep strategic thinking to existing or new patient advocacy programs PATIENT-FOCUSED DRUG DEVELOPMENT: Partnering with sponsors to develop strategies to bring the patient perspective into the clinical development process with the goal of identifying unmet medical needs, disease burden, and barriers to clinical trial participation POLICYMAKER EDUCATION: Working with patients to educate key government officials (e.g. Congress, FDA) on issues facing patient communities Research Funding & Positioning R&D FUTURES: Working with R&D leaders to envision, articulate, and communicate bold research initiatives with transformative impacts on human health PROPOSAL POSITIONING: Partnering with R&D leaders to ensure research proposals are positioned for success in a rapidly changing political environment NON-DILUTIVE FUNDING: Enabling research-entities to obtain non-dilutive sources of government funding for cutting edge research with a focus on ARPA-H, NIH, & CIRM